Search results
AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Zacks via Yahoo Finance Canada· 7 days agoAbbVie (ABBV) is seeking approval for Tepkinly in the EU as a monotherapy for the treatment of adult...
With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance Canada· 6 days agoKey Insights Significantly high institutional ownership implies AbbVie's stock price is sensitive to...
AbbVie cuts 2024 profit forecast on R&D expenses
Reuters via Yahoo Finance Canada· 4 days ago(Reuters) -AbbVie lowered its 2024 adjusted profit forecast on Wednesday, citing $937 million in milestones, and research and development expenses...
Cerevel Sued Over Stock Sale to Bain Ahead of AbbVie Deal News
Bloomberg Law· 5 days agoBain Capital LP affiliates may have arranged to buy stock on the cheap when they knew Cerevel Therapeutics Holdings Inc. was set to be acquired by AbbVie Inc. for $8.7 billion, a newly filed lawsuit says.
Drug companies challenge Minnesota prescription discount law in federal court
MPR News· 4 days agoSeveral drug companies filed lawsuits in federal court this week challenging a Minnesota law...
Company News for Jul 3, 2024
Zacks via Yahoo Finance Canada· 5 days agoShares of Apple Inc. AAPL rose 1.6% on the continued mega-cap growth stock rally. iQIYI, Inc.’s IQ shares rose 1.4% on consumer discretionaries scoring a...
Novo Nordisk, Lilly must cut US prices of weight-loss drugs, Biden says
Reuters via Yahoo Canada News· 6 days ago(Reuters) -U.S. President Joe Biden and Senator Bernie Sanders called on Novo Nordisk and Eli Lilly...
Euronext Paris Growth Leaders With High Insider Stakes July 2024
Simply Wall St. via Yahoo Finance Canada· 7 days agoAmid a backdrop of heightened political uncertainty and fluctuating market indices in France,...
Top Insider-Owned Growth Companies On Euronext Paris July 2024
Simply Wall St. via Yahoo Finance Canada· 6 days agoAmid a backdrop of heightened political uncertainty and fluctuating market indices, France's...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance Canada· 3 days agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...